Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysis

被引：0
|
作者：
Qing An
Zhihao Liu
机构：
[1] Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University,Institute for Health Education
[2] Jiangsu Provincial Center for Disease Control and Prevention,undefined
来源：
BMC Cancer | / 19卷
关键词：
Advanced melanoma; PD-1/L1 blockade; CTLA-4 blockade; BRAF inhibitor; MEK inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis
    Pippa, Corrie
    Nicolas, Meyer
    Rossana, Berardi
    Massimo, Guidoboni
    Maximilian, Schlueter
    Spyros, Kolovos
    Berengere, Macabeo
    Jean-Baptiste, Trouiller
    Philippe, Laramee
    CANCER TREATMENT REVIEWS, 2022, 110
  • [42] Efficacy comparison of immune combination therapies in subgroups for advanced hepatocellular carcinoma patients: Systematic review and network meta-analysis
    Wang, Yani
    Lau, Wanyee
    Li, Yafei
    Tian, Yichen
    Lei, Yongrong
    Xia, Feng
    Wang, Jianhua
    PLOS ONE, 2024, 19 (07):
  • [43] Efficacy and safety of first-line immune checkpoint inhibitor combination therapies in patients with advanced esophageal squamous cell carcinoma: a network meta-analysis
    Wang, Chenglong
    Cai, Tongze
    Wei, Jiangcun
    Huang, Ying
    Xiao, Lin
    Li, Tong
    Qin, Zujie
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [44] Comparison of the Efficacy and Safety of Disease-Modifying Antirheumatic Drugs Combination Therapies: A Systematic Review and Network Meta-Analysis
    Liu, Linfeng
    Ambe, Kaori
    Onishi, Mayu
    Yoshii, Yuka
    Makino, Toshiaki
    Tohkin, Masahiro
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (03):
  • [45] Efficacy comparison of monotherapies and combination therapies for androgenetic alopecia: A Bayesian network meta-analysis
    Chen, Dongyu
    Yang, Xiaoyu
    Liu, Xinghua
    He, Yuqing
    Fan, Wenlong
    Wang, Hongxin
    Lin, Yonghuang
    DERMATOLOGIC THERAPY, 2022, 35 (03)
  • [46] Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon
    Solange Whegang Youdom
    Andreas Chiabi
    Leonardo K. Basco
    Drugs in R&D, 2019, 19 : 1 - 14
  • [47] Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon
    Youdom, Solange Whegang
    Chiabi, Andreas
    Basco, Leonardo K.
    DRUGS IN R&D, 2019, 19 (01) : 1 - 14
  • [48] Comparative efficacy and safety of combination therapy with infliximab for Crohn’s disease: a systematic review and network meta-analysis
    Bing Han
    Daiyuan Tang
    Xiaodan Lv
    Shiquan Li
    Junhua Fan
    Xiaofang Xu
    Jiatong Zhang
    Shang Xu
    Weizheng Ye
    Ziqian Huang
    Lingling Zhan
    Xiaoping Lv
    International Journal of Colorectal Disease, 38
  • [49] Integrating efficacy and safety of vedolizumab and other advanced therapies for the treatment of ulcerative colitis: Results from a network meta-analysis
    Jairath, V.
    Lasch, K.
    Chan, K.
    Kanters, S.
    Jansen, J.
    Agboton, C.
    Patel, H.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S263 - S264
  • [50] Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials
    Lu, Fenping
    Zhao, Kai
    Ye, Miaoqing
    Xing, Guangyan
    Liu, Bowen
    Li, Xiaobin
    Ran, Yun
    Wu, Fenfang
    Chen, Wei
    Hu, Shiping
    BMC CANCER, 2024, 24 (01)
12345